601 related articles for article (PubMed ID: 29996645)
1. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
[TBL] [Abstract][Full Text] [Related]
2. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
Shah V; Choudhury BK
AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
[TBL] [Abstract][Full Text] [Related]
3. Transdermal Delivery of Pramipexole Using Microneedle Technology for the Potential Treatment of Parkinson's Disease.
McGuckin MB; Hutton ARJ; Davis ER; Sabri AHB; Ripolin A; Himawan A; Naser YA; Ghanma R; Greer B; McCarthy HO; Paredes AJ; Larrañeta E; Donnelly RF
Mol Pharm; 2024 May; 21(5):2512-2533. PubMed ID: 38602861
[TBL] [Abstract][Full Text] [Related]
4. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
[TBL] [Abstract][Full Text] [Related]
5. Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery.
Courtenay AJ; McAlister E; McCrudden MTC; Vora L; Steiner L; Levin G; Levy-Nissenbaum E; Shterman N; Kearney MC; McCarthy HO; Donnelly RF
J Control Release; 2020 Jun; 322():177-186. PubMed ID: 32200001
[TBL] [Abstract][Full Text] [Related]
6. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate.
Tekko IA; Chen G; Domínguez-Robles J; Thakur RRS; Hamdan IMN; Vora L; Larrañeta E; McElnay JC; McCarthy HO; Rooney M; Donnelly RF
Int J Pharm; 2020 Aug; 586():119580. PubMed ID: 32593650
[TBL] [Abstract][Full Text] [Related]
7. Advances in microneedle-based transdermal delivery for drugs and peptides.
Aich K; Singh T; Dang S
Drug Deliv Transl Res; 2022 Jul; 12(7):1556-1568. PubMed ID: 34564827
[TBL] [Abstract][Full Text] [Related]
8. Potential of hydrogel-forming and dissolving microneedles for use in paediatric populations.
Caffarel-Salvador E; Tuan-Mahmood TM; McElnay JC; McCarthy HO; Mooney K; Woolfson AD; Donnelly RF
Int J Pharm; 2015 Jul; 489(1-2):158-69. PubMed ID: 25940042
[TBL] [Abstract][Full Text] [Related]
9. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY
J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013
[TBL] [Abstract][Full Text] [Related]
10. Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride.
Migdadi EM; Courtenay AJ; Tekko IA; McCrudden MTC; Kearney MC; McAlister E; McCarthy HO; Donnelly RF
J Control Release; 2018 Sep; 285():142-151. PubMed ID: 29990526
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo evaluation of a microneedle array device for transdermal application.
Indermun S; Choonara YE; Kumar P; du Toit LC; Modi G; van Vuuren S; Luttge R; Pillay V
Int J Pharm; 2015 Dec; 496(2):351-9. PubMed ID: 26453791
[TBL] [Abstract][Full Text] [Related]
12. Microneedles: A smart approach and increasing potential for transdermal drug delivery system.
Waghule T; Singhvi G; Dubey SK; Pandey MM; Gupta G; Singh M; Dua K
Biomed Pharmacother; 2019 Jan; 109():1249-1258. PubMed ID: 30551375
[TBL] [Abstract][Full Text] [Related]
13. Local dermal delivery of cyclosporin A, a hydrophobic and high molecular weight drug, using dissolving microneedles.
Jeong HR; Kim JY; Kim SN; Park JH
Eur J Pharm Biopharm; 2018 Jun; 127():237-243. PubMed ID: 29432892
[TBL] [Abstract][Full Text] [Related]
14. Polymeric Microarray Patches for Enhanced Transdermal Delivery of the Poorly Soluble Drug Olanzapine.
McKenna PE; Abbate MTA; Vora LK; Sabri AH; Peng K; Volpe-Zanutto F; Tekko IA; Permana AD; Maguire C; Dineen D; Kearney MC; Larrañeta E; Paredes AJ; Donnelly RF
ACS Appl Mater Interfaces; 2023 Jul; 15(26):31300-31319. PubMed ID: 37349320
[TBL] [Abstract][Full Text] [Related]
15. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.
Donnelly RF; Garland MJ; Alkilani AZ
Methods Mol Biol; 2014; 1141():121-32. PubMed ID: 24567135
[TBL] [Abstract][Full Text] [Related]
16. Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization.
Yao G; Quan G; Lin S; Peng T; Wang Q; Ran H; Chen H; Zhang Q; Wang L; Pan X; Wu C
Int J Pharm; 2017 Dec; 534(1-2):378-386. PubMed ID: 29051119
[TBL] [Abstract][Full Text] [Related]
17. A key role by polymers in microneedle technology: a new era.
Rajput A; Kulkarni M; Deshmukh P; Pingale P; Garkal A; Gandhi S; Butani S
Drug Dev Ind Pharm; 2021 Nov; 47(11):1713-1732. PubMed ID: 35332822
[TBL] [Abstract][Full Text] [Related]
18. Touch-actuated microneedle array patch for closed-loop transdermal drug delivery.
Yang J; Chen Z; Ye R; Li J; Lin Y; Gao J; Ren L; Liu B; Jiang L
Drug Deliv; 2018 Nov; 25(1):1728-1739. PubMed ID: 30182757
[TBL] [Abstract][Full Text] [Related]
19. Nanosuspension-Loaded Dissolving Microneedle Patches for Enhanced Transdermal Delivery of a Highly Lipophilic Cannabidiol.
Cheng A; Zhang S; Meng F; Xing M; Liu H; Yang G; Gao Y
Int J Nanomedicine; 2024; 19():4061-4079. PubMed ID: 38736651
[TBL] [Abstract][Full Text] [Related]
20. Design, optimization, and evaluation for a long-time-released transdermal microneedle delivery system containing estradiol.
Tang X; Qin H; Zhang X; Yang H; Yang J; Chen P; Jin Y; Yang L
Drug Deliv Transl Res; 2024 Jun; 14(6):1551-1566. PubMed ID: 38062287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
